BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vautrin A, Manchon L, Garcel A, Campos N, Lapasset L, Laaref AM, Bruno R, Gislard M, Dubois E, Scherrer D, Ehrlich JH, Tazi J. Both anti-inflammatory and antiviral properties of novel drug candidate ABX464 are mediated by modulation of RNA splicing. Sci Rep 2019;9:792. [PMID: 30692590 DOI: 10.1038/s41598-018-37813-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Innocenti T, Bigagli E, Lynch EN, Galli A, Dragoni G. MiRNA-Based Therapies for the Treatment of Inflammatory Bowel Disease: What Are We Still Missing? Inflamm Bowel Dis 2023;29:308-23. [PMID: 35749310 DOI: 10.1093/ibd/izac122] [Reference Citation Analysis]
2 Ndashimye E, Reyes PS, Arts EJ. New antiretroviral inhibitors and HIV-1 drug resistance: more focus on 90% HIV-1 isolates? FEMS Microbiol Rev 2023;47. [PMID: 36130204 DOI: 10.1093/femsre/fuac040] [Reference Citation Analysis]
3 Nick M, Partridge FA, Forman R, Bataille CJ, Else KJ, Russell AJ, Sattelle DB. Screening the Medicines for Malaria Pandemic Response Box chemical library on Caenorhabditis elegans identifies re-profiled candidate anthelmintic drug leads.. [DOI: 10.1101/2022.08.10.503491] [Reference Citation Analysis]
4 Crespo R, Rao S, Mahmoudi T. HibeRNAtion: HIV-1 RNA Metabolism and Viral Latency. Front Cell Infect Microbiol 2022;12:855092. [DOI: 10.3389/fcimb.2022.855092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Shanley HT, Taki AC, Byrne JJ, Jabbar A, Wells TNC, Samby K, Boag PR, Nguyen N, Sleebs BE, Gasser RB. A High-Throughput Phenotypic Screen of the 'Pandemic Response Box' Identifies a Quinoline Derivative with Significant Anthelmintic Activity. Pharmaceuticals (Basel) 2022;15:257. [PMID: 35215369 DOI: 10.3390/ph15020257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Cai Z, Wang S, Li J. Treatment of Inflammatory Bowel Disease: A Comprehensive Review. Front Med (Lausanne) 2021;8:765474. [PMID: 34988090 DOI: 10.3389/fmed.2021.765474] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
7 Arenas AM, Andrades A, Patiño-mercau JR, Sanjuan-hidalgo J, Cuadros M, García DJ, Peinado P, Rodriguez MI, Baliñas-gavira C, Álvarez-perez JC, Medina PP. Opportunities of miRNAs in cancer therapeutics. MicroRNA in Human Malignancies 2022. [DOI: 10.1016/b978-0-12-822287-4.00015-3] [Reference Citation Analysis]
8 Ochman B, Kula A, Świętochowska E. The functional role of miRNAs in inflammatory pathways associated with intestinal epithelial tight junction barrier regulation in IBD. Postępy Higieny i Medycyny Doświadczalnej 2022;76:254-267. [DOI: 10.2478/ahem-2022-0038] [Reference Citation Analysis]
9 Ghafouri-Fard S, Mahmud Hussen B, Abak A, Taheri M, Abdulmajid Ayatollahi S. Emerging role of non-coding RNAs in the course of HIV infection. Int Immunopharmacol 2021;103:108460. [PMID: 34942460 DOI: 10.1016/j.intimp.2021.108460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Moron-Lopez S, Bernal S, Wong JK, Martinez-Picado J, Yukl SA. ABX464 decreases the total HIV reservoir and HIV transcription initiation in CD4 + T cells from HIV-infected ART-suppressed individuals. Clin Infect Dis 2021:ciab733. [PMID: 34436569 DOI: 10.1093/cid/ciab733] [Reference Citation Analysis]
11 Ben Ghezala I, Charkaoui M, Michiels C, Bardou M, Luu M. Small Molecule Drugs in Inflammatory Bowel Diseases. Pharmaceuticals (Basel) 2021;14:637. [PMID: 34209234 DOI: 10.3390/ph14070637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Vermeire S, Hébuterne X, Tilg H, De Hertogh G, Gineste P, Steens JM; ABX464 Investigators. Induction and Long-term Follow-up With ABX464 for Moderate-to-severe Ulcerative Colitis: Results of Phase IIa Trial. Gastroenterology 2021;160:2595-2598.e3. [PMID: 33662385 DOI: 10.1053/j.gastro.2021.02.054] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
13 Romano G, Acunzo M, Nana-Sinkam P. microRNAs as Novel Therapeutics in Cancer. Cancers (Basel) 2021;13:1526. [PMID: 33810332 DOI: 10.3390/cancers13071526] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
14 Raue R, Frank AC, Syed SN, Brüne B. Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment. Int J Mol Sci 2021;22:2210. [PMID: 33672261 DOI: 10.3390/ijms22042210] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
15 Gan L, Liao S, Xing Y, Deng S. The Regulatory Functions of lncRNAs on Angiogenesis Following Ischemic Stroke. Front Mol Neurosci 2020;13:613976. [PMID: 33613191 DOI: 10.3389/fnmol.2020.613976] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
16 Peng Y, Tao H, Satyanarayanan SK, Jin K, Su H. A Comprehensive Summary of the Knowledge on COVID-19 Treatment. Aging Dis 2021;12:155-91. [PMID: 33532135 DOI: 10.14336/AD.2020.1124] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
17 Lugnier C, Al-Kuraishy HM, Rousseau E. PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking. Biochem Pharmacol 2021;185:114431. [PMID: 33515531 DOI: 10.1016/j.bcp.2021.114431] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 15.0] [Reference Citation Analysis]
18 Tazi J, Begon-Pescia C, Campos N, Apolit C, Garcel A, Scherrer D. Specific and selective induction of miR-124 in immune cells by the quinoline ABX464: a transformative therapy for inflammatory diseases. Drug Discov Today 2021;26:1030-9. [PMID: 33387693 DOI: 10.1016/j.drudis.2020.12.019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
19 Blaess J, Walther J, Petitdemange A, Gottenberg JE, Sibilia J, Arnaud L, Felten R. Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage. Ther Adv Musculoskelet Dis 2020;12:1759720X20959971. [PMID: 33403019 DOI: 10.1177/1759720X20959971] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
20 Lee LK, Medzikovic L, Eghbali M, Eltzschig HK, Yuan X. The Role of MicroRNAs in Acute Respiratory Distress Syndrome and Sepsis, From Targets to Therapies: A Narrative Review. Anesth Analg 2020;131:1471-84. [PMID: 33079870 DOI: 10.1213/ANE.0000000000005146] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
21 Meydan C, Madrer N, Soreq H. The Neat Dance of COVID-19: NEAT1, DANCR, and Co-Modulated Cholinergic RNAs Link to Inflammation. Front Immunol 2020;11:590870. [PMID: 33163005 DOI: 10.3389/fimmu.2020.590870] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
22 Bauer M, Vaxevanis C, Heimer N, Al-Ali HK, Jaekel N, Bachmann M, Wickenhauser C, Seliger B. Expression, Regulation and Function of microRNA as Important Players in the Transition of MDS to Secondary AML and Their Cross Talk to RNA-Binding Proteins. Int J Mol Sci 2020;21:E7140. [PMID: 32992663 DOI: 10.3390/ijms21197140] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
23 Wajda A, Łapczuk-Romańska J, Paradowska-Gorycka A. Epigenetic Regulations of AhR in the Aspect of Immunomodulation. Int J Mol Sci 2020;21:E6404. [PMID: 32899152 DOI: 10.3390/ijms21176404] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
24 Bushell W, Castle R, Williams MA, Brouwer KC, Tanzi RE, Chopra D, Mills PJ. Meditation and Yoga Practices as Potential Adjunctive Treatment of SARS-CoV-2 Infection and COVID-19: A Brief Overview of Key Subjects. J Altern Complement Med 2020;26:547-56. [PMID: 32579021 DOI: 10.1089/acm.2020.0177] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 10.7] [Reference Citation Analysis]
25 Lin L, Zhou G, Chen P, Wang Y, Han J, Chen M, He Y, Zhang S. Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease? Cell Death Dis 2020;11:456. [PMID: 32541691 DOI: 10.1038/s41419-020-2657-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
26 Psomas CK, Salzwedel K, Stevenson M, Poli G, Routy JP, Margolis D, Chomont N, Lafeuillade A. Highlights of the 9th edition of the Conference on HIV Persistence During Therapy, 10-13 December 2019, Miami, USA. J Virus Erad 2020;6:85-95. [PMID: 32405427] [Reference Citation Analysis]
27 Psomas C, Salzwedel K, Stevenson M, Poli G, Routy J, Margolis D, Chomont N, Lafeuillade A. Highlights of the 9th edition of the Conference on HIV Persistence During Therapy, 10–13 December 2019, Miami, USA. Journal of Virus Eradication 2020;6:85-95. [DOI: 10.1016/s2055-6640(20)30022-4] [Reference Citation Analysis]
28 Tsagakis I, Douka K, Birds I, Aspden JL. Long non-coding RNAs in development and disease: conservation to mechanisms. J Pathol 2020;250:480-95. [PMID: 32100288 DOI: 10.1002/path.5405] [Cited by in Crossref: 75] [Cited by in F6Publishing: 83] [Article Influence: 25.0] [Reference Citation Analysis]
29 Shivaji UN, Nardone OM, Cannatelli R, Smith SC, Ghosh S, Iacucci M. Small molecule oral targeted therapies in ulcerative colitis. Lancet Gastroenterol Hepatol 2020;5:850-61. [PMID: 32171056 DOI: 10.1016/S2468-1253(19)30414-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
30 Stoszko M, Ne E, Abner E, Mahmoudi T. A broad drug arsenal to attack a strenuous latent HIV reservoir. Curr Opin Virol 2019;38:37-53. [PMID: 31323521 DOI: 10.1016/j.coviro.2019.06.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
31 Delannoy A, Poirier M, Bell B. Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies. Viruses 2019;11:E269. [PMID: 30889861 DOI: 10.3390/v11030269] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]